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Background: Information about longer-term functional outcomes following lower extremity amputation for peripheral
vascular disease and diabetes remains limited. This study examined factors associated with mobility success during the
first year following amputation.
Methods: Prospective cohort study of 87 amputees experiencing a first major unilateral amputation surgery. Seventy-five
(86%) participants completed 12-month follow-up interview.
Results: Twenty-eight subjects (37%) achievedmobility success, defined as returning to or exceeding a baseline level of mobility on
the locomotor capability index (LCI-5). Forty-three subjects (57%)were satisfiedwith theirmobility. Individualswhowere65years
of age and older (risk difference [RD]  0.52; 95% confidence interval [CI]: 0.75, 0.29), reported a current alcohol use
disorder (RD0.37; 95%CI:0.48,0.26), had ahistory of hypertension (RD0.23; 95%CI:0.43,0.03) or treatment
for anxiety or depression (RD0.39; 95% CI:0.50,0.28) were less likely to achieve mobility success. Mobility success was
associated withmobility satisfaction (RD 0.36; 95%CI: 0.20, 0.53) and satisfaction with life (RD 0.28; 95%CI: 0.06, 0.50).
Although higher absolute mobility at 12 months was also associated with mobility satisfaction and overall life satisfaction, 50% of
individualswhoachieved successwith low tomoderate12-monthmobility function reported theywere satisfiedwith theirmobility.
Conclusion:Defining success after amputation in relation to an individual’s specific mobility prior to the development of limb
impairment which led to amputation provides a useful, patient-centered measure that takes other aspects of health, function,
and impairment into account. (J Vasc Surg 2011;54:412-9.)
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SChallenges in quantifying and predicting outcome after
lower extremity amputation (LEA) secondary to peripheral
vascular disease (PVD) and/or diabetes can limit effective
and consistent health care decision-making. Defining suc-
cessful outcome is particularly challenging when superim-
posed upon aging and impairments related to the underly-
ing disease processes.1 Additionally, various stakeholders
(eg, patient, surgeon, third party payer) may prioritize
outcomes differently (eg, mortality, hospitalization, mobil-
ity, self-care, social integration, and satisfaction with life
and/or quality of life).2-7 In an initial effort to address these
complexities, Taylor defined successful outcome based on a
combination of survival, amputation wound healing, and
mobility (defined as daily ambulation with a prosthesis for 1
year or until death).8
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412To date, mobility has been the functional outcome most
ommonly examined postamputation. However, new methods
re needed to ensure that measures quantify aspects of mobility
hat are important to the patient, incorporate the patient’s pre-
orbid functional status, and provide health care providers with
seful information at key decision points in the amputation
ontinuum of care.9 To address these challenges, we propose a
ew definition of mobility outcome, “mobility success,” based
n the rehabilitation tenet that amputation is a functionally re-
toring procedure and that success is defined not only relative to
he impairment necessitating the surgical procedure, but also
elative to the additional impairments that affect mobility at
aseline.10 Thus, patients with relatively low levels of underlying
obility can be viewed as having a successful outcome if they
eturn to this level of function after amputation.
The objectives of this study were (1) to utilize the novel
efinition of “mobility success” to describe mobility outcome
fter LEA due to PVD and diabetes; (2) to compare rates of
obility success between various amputation levels; (3) to eval-
ate factors, independent of amputation level, associated with
obility success; (4) to explore the definition ofmobility success
y examining its association with satisfaction with mobility and
atisfaction with life; and (5) to determine if the new mobility
uccess variable adds to the utility ofmore traditional approaches
o measuringmobility in this population.
ETHODS
tudy design
We performed a multisite prospective cohort study of
ndividuals undergoing major lower extremity amputation
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Volume 54, Number 2 Norvell et al 413due to complications of PVD or diabetes at two-VA med-
ical centers (VA Medical Center, Puget Sound and Den-
ver), a university hospital (University of Colorado Medical
Center, Denver), and a level I trauma center (Harborview
Medical Center, Seattle). The decision to perform trans-
metatarsal (TM), transtibial (TT), or transfemoral (TF)
amputation was made at each site per usual care. Partici-
pants were assessed via in-person or telephone interview at
four time points: presurgically (if available), 6 weeks, 4
months, and 12 months postsurgically. Patients not avail-
able presurgically were enrolled at 6 weeks (Fig 1). Addi-
tional data were gathered via systematic review of the
medical records. Only the premorbid data obtained at 6
weeks and the 12-month follow-up data are presented here.
The 6-week and 4-month outcomes/follow-up data were
not included in this report because these were considered
intermediate outcomes rather than the ultimate level of
functional mobility. All assessments were performed by a
trained study coordinator designated for each site who was
responsible for recruitment, interviews and completion of
case report forms, and routine monitoring of all enrolled
patients. This study was conducted in accordance with the
procedures approved by local human subjects review
boards.
Participants
Two hundred thirty-nine individuals were screened for
participation between September 2005 and December
2008. Subjects were considered eligible if (1) they were age
18 years or older, (2) they were awaiting (or underwent in
the last 6 weeks) a first major amputation (defined as TM
level or higher), and (3) the primary cause of amputation
was complications of diabetes or PVD. Criteria for a dys-
vascular amputation etiology were met if the medical re-
cord confirmed that the amputation was necessitated by
peripheral vascular disease and/or diabetes, and there was
no significant history of extremity trauma or tumor. Sub-
Fig 1. Time points for assessing level of mobility from
patient’s recall of his or her mobility before a decline
amputation. One subject died after enrollment before th
**Subjects who were enrolled presurgically completed
premorbid mobility. These two scores demonstrated stro
(P  .003).jects were excluded if: (1) they had inadequate cognitive or tanguage function to consent or participate, defined by6
rrors on the Short Portable Mental Status Questionnaire,
r (2) they were nonambulatory before the amputation for
easons unrelated to PVD or diabetes. Of the 239 individ-
als screened, 136 (57%) met study criteria. Thirteen sub-
ects were excluded as we were unable to verify eligibility
ue to privacy standards at one facility. Eighty-seven sub-
ects (64%) participated (Fig 2).
rocedures
Presurgical assessment. The presurgical status assess-
ent was comprised of information collected via interview
nd verified via medical record review. Measures included
emographics, information about the index amputation,
ealth factors, and mobility. Time between the decision to
mputate and surgery was often brief, and we were unable
o enroll all subjects prior to surgery. Subjects enrolled
rior to surgery (n  29, 33%) completed the presurgical
tatus assessment at the time of enrollment, while those
nrolled 6 weeks postsurgically completed a retrospective
ssessment of their presurgical status. Retrospective ques-
ions were as identical as possible to questions on the
resurgical battery. The study coordinator prefaced the
uestions by saying, “In the following questions, we are
sking you to tell us about your life and health in the week
EFORE your amputation.”
The primary etiology and the anatomic level of am-
utation was categorized as TM, TT, or TF as reported
n the medical record and confirmed during interview.
he Charlson comorbidity index11 was used to deter-
ine the presence of presurgical comorbid conditions.
dditional comorbid conditions hypothesized to be rel-
vant in these populations were also assessed, see Table I.
moking status was assessed by three standard questions
rom the VA Large Health Survey. Subjects were consid-
red smokers if they endorsed smoking “every day” or
some days” prior to amputation, and non-smokers if
orbid function to 12 months after amputation. *The
unction due to disability in the limb that underwent
omotor capability index (LCI) score could be assessed.
CI questionnaire then and at 6 weeks to assess their
reement with a Spearman correlation coefficient of 0.83prem
in f
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August 2011414 Norvell et alall.” A three-item version of the Alcohol Use Disorders
Identification Test (AUDIT-C) was used to assess alco-
hol consumption patterns in the past year.12 Possible
scores range from 0 to 12, with higher scores indicating
greater alcohol misuse severity, and a score of “4 or
more” and “3 or more” identifying alcohol misuse in
men and women, respectively. To ensure the reliability of
presurgical recall, we evaluated the test–retest reliability
comparing presurgical with 6 week postsurgery self-
report among the participants enrolled presurgically.
The  coefficient for smoking was 0.53 (P .03) and the
intraclass correlation coefficient for total AUDIT-C
score was 0.98 (P  .001), suggesting that retrospective
recall 6 weeks after surgery is a reliable way to assess
premorbid status, especially for alcohol use. All presur-
gical assessment measures are presented in Table I.
Follow-up assessments. Follow-up interviews were
obtained 12 months postamputation by in-person inter-
view if possible, otherwise via telephone. Global
Fig 2. Diagram depicting sccomparisons of telephone and in-person interviews have ponsistently demonstrated strong agreement across
any types of measures, such as health behaviors and
ental health issues, suggesting this is a reasonable
ethod.13-15
rimary outcome measure: Mobility success
Mobility success was defined dichotomously. Success
ccurred when the level of mobility at 12 months was the
ame as or greater than the premorbid mobility level. The
evel of mobility at each time period was measured using
he locomotor capability index (LCI-5). The LCI-5 con-
ists of 14 items graded on a five-level ordinal scale ranging
rom unable to perform the activity (0), to able to perform
lone without aids.4,16 Scores for the LCI-5 range from 0
o 56 with higher scores representing higher function. The
CI-5 has well-established internal consistency, test–retest
eliability, and validity. Additionally, it has a lower ceiling
nd a larger effect size than the original LCI, making it an
ppropriate tool for detecting functional change in this
g and enrollment numbers.opulation.16
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Volume 54, Number 2 Norvell et al 415Premorbidmobility was defined as the level of mobility
prior to the development of disability (eg, ulcer, edema,
associated pain) in the limb undergoing amputation. Sub-
jects who reported disability in their amputated limb were
asked to complete the LCI-5 based on their function
“immediately prior to developing any limitations in your
leg awaiting amputation.”
Premorbidmobility was collected 6 weeks after surgery
for all enrolled subjects (n  86; one subject passed away
after enrollment before function could be assessed). For the
Table I. Baseline socio-demographic and general health d
Variable TM (n  27)
Age 63.0  7.8
Female 0 (0)
BMI 29.8  6.0
Marital status
Not married/partner 9 (33)
Married/partner 18 (67)
Race
Caucasian 19 (70)
Black 6 (22)
Other 2 (7)
Employment status
Not employed 27 (100)
Employed 0 (0)
Education level
Some high school 2 (7)
High school grad 3 (6)
College grad 0 (0)
Living status
Home alone 9 (33)
Home with spouse/other 16 (59)
SNF/nursing home 1 (4)
Other 1 (4)
Socioeconomic status
25,000
25,001-50,000
50,000
12 (44)
8 (30)
7 (26)
Charlson
Low 8 (30)
Moderate 6 (22)
High 9 (33)
Very high 4 (15)
Diabetesb 27 (100)
Strokeb 5 (19)
Heart attackb 9 (33)
Dialysisb 11 (41)
Chronic obstructive pulmonary diseaseb 1 (4)
Lower extremity arterial reconstruction 11 (41)
Traumatic brain injury 8 (30)
Joint replacement 2 (7)
Hypertension 19 (70)
Posttraumatic stress disorder 3 (11)
Smoker 5 (19)
Alcohol consumption
Negative screen 24 (89)
Positive or serious disorder 3 (11)
Premorbid LCI score 49.1  9.8
LCI, Locomotor capability index; SNF, skilled nursing facility; TF, transfem
aIncomplete numbers represent missing values.
bComorbidities obtained from the Charlson comorbidity index.
cP value based on analysis of variance (ANOVA) for age and body mass ind29 subjects recruited presurgically, premorbid mobility was mlso collected prior to amputation, at the time of enroll-
ent. To assess the reliability of our retrospective premor-
id mobility measure, the responses at the two time periods
ere compared. The intraclass correlation of the 6-week
ostsurgically assessed premorbid score (agreement if recall
as within three points) to the presurgical recall of the
remorbid score was 0.87 (P .003). To further ensure the
eliability of the mobility measure, the 6-week recall of
remorbidmobility was compared between those recruited
resurgically and those recruited post surgically, and the
y amputation levela
TT (n  52) TF (n  8) P valuec
61.5  9.1 62.5  10.0 .61
6 (12) 1 (13) .18
31.6  7.8 34.0  9.0 .15
.35
25 (48) 4 (57)
27 (52) 3 (43)
.23
46 (88) 8 (100)
3 (6) 0 (0)
3 (6) 0 (0)
.10
44 (85) 6 (86)
8 (15) 1 (14)
.85
18 (67) 7 (26)
39 (75) 10 (19)
6 (86) 1 (14)
.69
13 (25) 4 (57)
33 (64) 3 (43)
4 (8) 0 (0)
2 (4) 0 (0)
.57
24 (46)
21 (40)
7 (14)
2 (29)
3 (43)
2 (29)
.83
9 (17) 1 (14)
16 (31) 2 (29)
15 (29) 2 (29)
12 (23) 2 (29)
44 (85) 4 (50) .001
11 (21) 1 (13) .84
17 (33) 3 (38) .97
19 (37) 2 (29) .83
7 (13) 1 (13) .39
19 (37) 2 (29) .83
11 (21) 3 (43) .39
5 (10) 1 (14) .85
33 (64) 7 (88) .38
8 (15) 1 (14) .87
22 (42) 5 (71) .02
.54
42 (81) 5 (71)
10 (19) 2 (29)
47.1  12.3 47.9  8.9 .76
TM, transmetatarsal; TT, transtibial.
I), and on 2 test for the categorical variables.ata b
oral;ean difference was only 1.6 points (P .52). The 6-week
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August 2011416 Norvell et alrecall of premorbid mobility was therefore used as the basis
for the determination of mobility success for all subjects.
Secondary outcome measures: Satisfaction with
mobility and satisfaction with life
Satisfaction with mobility at 12 months was deter-
mined through a single item created for this study: “How
satisfied are you with your current walking ability?” Sub-
jects responded using a 0 to 10 point Likert scale where 0
represented “not at all satisfied” and 10 “extremely satis-
fied.” A mean score of 6 on this scale was defined as
“satisfied.” To measure more global life satisfaction, we
used the Satisfaction with Life Scale (SWLS).17 This five-
item measure is designed to measure the judgmental or
cognitive component of subjective well-being. Each item is
scored on a Likert scale, with response options ranging
from 1 (strongly disagree) to 7 (strongly agree). Items are
summed, such that possible scores range from 5 to 35, and
higher scores indicate greater satisfaction. The measure
possesses good internal consistency, test–retest reliability,
and validity.18 The 12-month median score was 19; there-
fore, we considered a score of 20 points or above as
“satisfied” and a score of less than 20 points as “unsatis-
fied.”
Data analysis
Descriptive statistics of presurgical variables are pre-
sented in Table I. Differences by amputation level for
categorical and continuous variables were made using Pear-
son 2 tests and analysis of variance (ANOVA), respec-
tively. Multivariate associations of presurgical factors with
mobility success were examined using forward stepwise
negative binomial regression with risk differences (RD) and
95% confidence intervals (CI). Only variables with adjusted
P values .05 were included in the final models. Amputa-
tion level was included in the final model regardless of
statistical significance. All variables listed in Table I were
assessed.
Utility of mobility success outcome measure
We examined the utility of “mobility success” as an
outcome measure through a series of analyses. First, we
examined if there was a positive association between mo-
bility success and both satisfaction with mobility and satis-
Table II. Success rates and LCI-5 baseline, 12-month foll
12-month follow-up
Mobility TM (n  26)
Success rate (%) 35
Premorbid LCI-5 score 49.1  9.8
12-month LCI-5 score 43.2  12.5
Change score 5.9  11.5
LCI, Locomotor capability index; TF, transfemoral; TM, transmetatarsal; T
aPearson 2 test.
bComparing between group change scores using analysis of variance.faction with life. Second, we determined if the mobility success measure was able to identify individuals with low to
oderate levels of mobility at 12months whomight still be
erceived as having a successful outcome because they
eturned to their previous level of function and were satis-
ed with mobility. To accomplish this, we categorized the
CI 12-month scores into three levels based on the total
core for each column of response categories. We created
ategories described as “needing help from others,” “need-
ng help from ambulation aids,” and “independent” using
he following cutoffs, respectively: 0 to 27, 28 to 42, and 42
o 56 points, respectively.
ESULTS
Baseline characteristics. Among the 87 participants
nrolled, four participants (5%) formally withdrew, two
ere lost to follow-up (2%), and six participants (7%) passed
way over 12-month follow-up period. Seventy-five partic-
pants completed their 12-month interview (86%) (Fig 2).
he majority of the 87 subjects enrolled in the study were
T (60%) followed by TM (31%) amputees. One partici-
ant had a knee disarticulation that was classified as a TF
mputation. Most baseline demographics and health fac-
ors were similar across amputation levels. However, all
ubjects were unemployed (retired or not employed) in the
M group while a small proportion were employed in the
T and TF groups. Additionally, there was a significantly
P  .01) larger proportion of individuals with diabetes in
he TMgroup (100%) compared with the TT (85%) and TF
roups (50%). The proportion of smokers increased with
igher levels of amputation: 19%, 42%, and 71% for TM,
T, and TF amputees, respectively (P  .05). It is also
oteworthy that premorbid mobility (as measured by the
CI score prior to disability) was similar between all ampu-
ation levels, Table II (P  .76).
Mobility success rates by amputation level. As
hown in Table II, the mean change in mobility from
remorbid function to 12 months after surgery for each
mputation group was negative, ie, there was a decline in
obility over time. The differences were not statistically
ignificant, despite a large decrease in mobility among the
F group. This is likely due to the small sample of TF
ubjects. Overall, 28 subjects (37%) achieved mobility suc-
ess, and rates of mobility success were comparable across
mputation levels (35% TM, 41%TT, and 29%TF, P .78,
p, and change scores among those who achieved their
T (n  42) TF (n  7) P value
41 29 .78a
7.1  12.3 47.9  8.9
0.7  16.2 33.0  20.9
6.4  14.7 14.9  7.3 .19b
stibial.ow-u
T
4
4

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Volume 54, Number 2 Norvell et al 417Factors associated with mobility success. As shown
in Table III, controlling for amputation level, those sub-
jects who were 65 years or older had a 52% lower success
rate than subjects 45 to 54 years of age (RD0.52; 95%
CI: 0.75, 0.29, P  .001). Subjects with an alcohol
disorder had a 37% lower success rate than those without a
disorder (RD0.37; 95% CI:0.48,0.26, P .001).
Subjects with hypertension had a 23% lower success rate
than those without hypertension (RD  0.23; 95% CI:
0.43, 0.3, P  .02), and those who had been treated
previously for anxiety or depression had a 39% lower success
rate than those who had not (RD  0.39; 95% CI:
0.50, 0.28, P  .001).
Association between mobility success and mobility
satisfaction and satisfaction with life. Among subjects
who reached the 12-month follow-up, 57% (n  43) were
satisfied with their mobility (62%, 50%, and 29% for TM,
TT, and TF, respectively). Among the subjects who
achieved mobility success (n 28), 20 (71%) were satisfied
with their mobility and eight (29%) were dissatisfied. When
controlling for amputation level, age, and alcohol disorder,
those who achieved mobility success had a 36% higher
mobility satisfaction rate than those who did not achieve
success (RD  0.36; 95% CI: 0.20, 0.53, P  .001).
Transfemoral amputees had a 32% lower mobility satisfac-
tion rate than TM amputees (RD  0.32; 95% CI:
0.60, 0.04, P  .03). There was no statistically signifi-
cant difference between TT and TM amputees.
Similarly, those who achieved mobility success at 12
months were more likely to be satisfied with life than those
that did not (61% vs 34%, respectively; P  .02) and
similarly had higher mean SWLS scores (22.8  8.4 vs
17.7  8.3, respectively; P  .01). When controlling for
Table III. Multivariate results for 12-month mobility
success
Risk factor RDa (95% CI)
P
value
Amputation levelb
TT 0.17 (0.02, 0.36) .08
TF 0.06 (0.13, 0.26) .50
Agec
55-64 years 0.10 (0.36, 0.15) .43
65 years 0.52 (0.75, 0.29) .001
HTN (yes) 0.23 (0.43, 0.03) .02
AUD (yes)d 0.37 (0.48, 0.26) .001
MH TX (yes) 0.39 (0.50, 0.28) .001
AUD, Alcohol use disorder; CI, confidence interval; HTN, hypertension;
MH TX, prior treatment for anxiety or depression; RD, risk difference; TF,
transfemoral; TM, transmetatarsal; TT, transtibial.
aRisk differences generated from a negative binomial regression model
represent an increase (or decrease if negative) in the success rate relative to
reference category.
bTM  reference category.
c45 to 54 years  reference category.
dpositive screen or serious alcohol disorder; negative for alcohol disorder 
reference category.amputation level, those who achieved mobility success had q28% higher satisfaction with life rate than those who did
ot (RD  0.28; 95% CI: 0.06, 0.50, P  .01).
Association between 12-month LCI scores and sat-
sfaction scores. When controlling for amputation level,
ge, baseline mobility, prior stroke, and presence of chronic
bstructive pulmonary disease, 12-month satisfaction with
obility was significantly associated with the 12-month
CI score (coefficient  15.186; P  .001), suggesting
hat those with higher mobility scores were more likely to
e satisfied with their mobility.
When controlling for amputation level, age, baseline
obility, prior stroke, and presence of chronic obstructive
ulmonary disease, 12-month satisfaction with life was
ignificantly associated with the 12-month LCI score (co-
fficient  8.159; P  .01), suggesting that those with
igher mobility scores were more likely to be satisfied with
ife.
Benefits gained with the mobility success outcome
ersus mobility score. Since both mobility success and
2-month LCI scores were significantly associated with
obility satisfaction and life satisfaction, we attempted to
etermine if any benefit is gained by using the mobility
uccess score. We were interested in subjects with low to
oderate mobility levels at 12 months who also met the
riteria for mobility success. These were subjects who one
ight assume would not be satisfied with mobility or life
ased on their lower 12-month mobility scores. If a reason-
ble proportion of these subjects were also satisfied, then
erhaps our measure of mobility success adds additional
alue to the assessment of outcome after amputation. Six of
he 28 who achieved mobility success (21%) were catego-
ized as “needing help from others” (28 points) to
needing help from ambulation aids” (28-42 points) 12
onths after surgery. Three of these six (50%) were satisfied
ith their mobility. Two of the six (33%) were satisfied with
ife so we did identify individuals who ordinarily may have
een considered failures or poor outcomes due to their
ower 12-month LCI scores.
ISCUSSION
The primary goal of this investigation was to describe a
ovel approach to the measurement of “mobility success”
hat could account for the sum total of underlying impair-
ents and comorbidities predating the amputation. Fur-
her, this definition does not base success simply on how
ell the patient is functioning 12 months after surgery,
ather, it quantifies success based on the patient’s final level
f mobility relative to disability preceding the amputation.
n exploring the utility of this approach, we examined the
elationship between mobility success, satisfaction with
obility, and satisfaction with life. Additionally, this inves-
igation compared “mobility success” across amputation
evels and identified patient-related variables associated
ith mobility success.
There is increasing recognition of the importance of
atient-reported measures when examining lower extrem-
ty amputation outcomes.9 The surgical care and subse-
uent rehabilitation process after amputation seeks to op-
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August 2011418 Norvell et altimize and restore the physical, mental, emotional, social,
vocational, and economic outcome of each patient.19 To
our knowledge, there are no measures of adequate com-
plexity and comprehensiveness to evaluate all of these do-
mains, and efforts to define successful outcome have re-
ceived very limited study. Although focused on surgical
outcome for critical limb ischemia, Landry argues that
improvements in functional status are difficult to define
because of the numerous and often severe comorbid con-
ditions in this patient population.9 He and others20 suggest
that it is the improvement in function relative to a baseline
functional status that is critical. Mobility has been one of
the key outcomes used to quantify functional improvement
after amputation. A number of investigators have at-
tempted to quantify differences between pre- and post-
amputation mobility21-23 but have not identified returning
to or exceeding pre-amputation mobility as a measure of
success. In this study, mobility success allows mobility to be
assessed in the context of background psychological, phys-
ical, and social factors that may contribute to mobility
impairment. At 12 months, only 37% of patients achieved
mobility success. The factors associated with a failure to
achieve mobility success controlling for amputation level
were age 65 years or older, alcohol disorder, hypertension,
and previous history of being treated for anxiety or depres-
sion. The contributions of these factors to mobility out-
come have been evaluated by previous studies using other
mobility measures, often using cross-sectional or retrospec-
tive study designs and often without multivariate analyses.
They have confirmed the adverse effect of increasing age on
outcome,22-24 as well as the association between anxiety
and depression and ongoing activity limitation.25,26 The
association between alcohol use disorder and mobility in
amputees has received little study. One of the major advan-
tages of this prospective study over cross-sectional studies is
that we can be sure these exposures preceded the outcome.
In contrast to previous investigations that suggest the
more distal the amputation level the better the mobility
outcome,4,22 this investigation did not show a significant
relationship between amputation level and mobility suc-
cess. The absence of a significant difference in mobility
outcome after TF amputation compared with the more
distal amputation levels is likely related to the very small
number of TF amputees in the study population, and the
variability in their mobility measures. There was a nonsig-
nificant trend suggesting the mobility success rate for TT
amputees was 17% higher than in TM amputees (P .08).
This finding is counterintuitive given the current emphasis
on preserving as much limb length as possible to maximize
the restoration of mobility. Baseline demographic data
showed that TM amputees were less likely to be smokers
but more likely to have diabetes than those who underwent
more proximal amputation levels. The increased frequency
of diabetes may have been associated with the presence of
multiple diabetes-related comorbidmedical conditions that
were not accounted for in the Charlson comorbidity index,
which was designed primarily to predict the effect of co-
morbid medical conditions on mortality. aOne of the key considerations in evaluating any out-
ome measure is whether or not it is valid and relevant to
atients. The relationship between level of mobility and
atient satisfaction in lower extremity amputees has re-
eived limited study. Some suggest a relationship between
alking ability and life satisfaction,27 while others show no
elationship.28 Our study did identify a relationship be-
ween mobility success and mobility satisfaction as well as
atisfaction with life. Those who achieved mobility success
ere 36% more likely to be satisfied with their mobility and
8% more likely to be satisfied with life than those who did
ot. The significant correlations suggest that mobility suc-
ess is a measure that is relevant and important from a
atient perspective.
Several limitations of the current study are worthy of
ote. The sample was restricted to patients with at least a
inimum level of ambulatory function prior to amputation
nd with the cognitive capacity to participate in an inter-
iew, limiting generalization. In addition, the primary am-
ulation outcome was collected through interview andmay
e subject to the limitations of self-report. Concerns about
his issue are at least partially mitigated by the positive
sychometric properties of the LCI, and a strong move-
ent toward patient reported outcomes for outcomes re-
earch. Additionally, recent investigation has shown that
here is a high level of correlation between capacity and
erformance measures in lower extremity amputees. Spe-
ifically the LCI-5 used in this study was strongly correlated
ith the 2-minute walk test and the timed get up and go
est.29 We based our definition of mobility success on what
e defined as premorbid mobility. This represented mobil-
ty prior to a decline in function that commonly occurs as a
esult of disability in the limb awaiting amputation and
omorbid disease. It is possible that asking subjects to recall
heir premorbid mobility 6 weeks after surgery was subject
o recall bias, although the time period was brief, and a
est–retest reliability subsample of our presurgical enrollees
emonstrated strong agreement between time points. We
lso had subjects recall some of their presurgical risk factors
o include smoking and alcohol. With alcohol, which was a
ovariate in our final model, there was near perfect agree-
ent. The majority of the other presurgical factors we were
ble to verify in the medical record. Our overall sample size
imited the ability to examine characteristics of specific
mputation types (most notably TFs) in greater detail but
e believe the final number we achieved was noteworthy
iven the prospective nature of the study.
ONCLUSION
We have reported a novel method for measuring mo-
ility success that allows the evaluation of mobility in the
ontext of a patient’s premorbid mobility level. This allows
he incorporation of the effects of premorbid mobility
mpairments in this population with a high incidence of
omorbidities. The utility of this proposed measure is
trengthened by its significant relationship with satisfaction
ith mobility and satisfaction with life. We have also shown
mputation level is not significantly associated with mobil-
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Volume 54, Number 2 Norvell et al 419ity success and have determined the importance of various
presurgical risk factors on mobility success. These include
subjects 65 years of age and older, those with an alcohol
disorder, hypertension, and previous history of being
treated for anxiety or depression.
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